Great-West Lifeco (TSE:GWO - Get Free Report) had its price target boosted by investment analysts at CIBC from C$46.00 to C$51.00 in a report issued on Wednesday, BayStreet.CA reports. The brokerage presently has a "neutral" rating on the stock. CIBC's target price suggests a potential upside of 7.66% from the company's current price.
Other equities research analysts have also recently issued research reports about the company. Royal Bank of Canada raised their price objective on Great-West Lifeco from C$45.00 to C$47.00 in a report on Thursday, August 8th. Jefferies Financial Group lifted their price target on Great-West Lifeco from C$42.00 to C$48.00 and gave the company a "hold" rating in a report on Wednesday, October 16th. Barclays set a C$43.00 price objective on shares of Great-West Lifeco and gave the stock an "underweight" rating in a report on Thursday, September 5th. Scotiabank upped their price target on shares of Great-West Lifeco from C$44.00 to C$50.00 and gave the stock a "sector perform" rating in a research report on Wednesday. Finally, TD Securities lifted their price target on shares of Great-West Lifeco from C$43.00 to C$44.00 and gave the company a "hold" rating in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of C$46.38.
View Our Latest Report on GWO
Great-West Lifeco Stock Performance
Shares of Great-West Lifeco stock traded down C$0.10 on Wednesday, hitting C$47.37. The stock had a trading volume of 347,284 shares, compared to its average volume of 2,643,094. The company's 50 day moving average price is C$45.64 and its 200 day moving average price is C$42.59. Great-West Lifeco has a 52-week low of C$38.12 and a 52-week high of C$47.76. The stock has a market cap of C$44.16 billion, a price-to-earnings ratio of 11.90, a P/E/G ratio of 2.26 and a beta of 0.84. The company has a current ratio of 37.46, a quick ratio of 22.18 and a debt-to-equity ratio of 29.61.
Great-West Lifeco (TSE:GWO - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported C$1.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of C$1.05 by C$0.06. The company had revenue of C$8.61 billion during the quarter, compared to the consensus estimate of C$9.83 billion. Great-West Lifeco had a net margin of 11.32% and a return on equity of 13.21%. On average, research analysts anticipate that Great-West Lifeco will post 4.4525194 EPS for the current year.
Insiders Place Their Bets
In other Great-West Lifeco news, Director Charles Donald Harvey Henaire sold 25,400 shares of the stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of C$44.72, for a total value of C$1,135,888.00. In other Great-West Lifeco news, Director Richard Henry Linton sold 35,800 shares of the business's stock in a transaction on Friday, October 4th. The stock was sold at an average price of C$46.27, for a total transaction of C$1,656,344.28. Also, Director Charles Donald Harvey Henaire sold 25,400 shares of the stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of C$44.72, for a total value of C$1,135,888.00. 70.70% of the stock is currently owned by corporate insiders.
Great-West Lifeco Company Profile
(
Get Free Report)
Great-West Lifeco Inc engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, disability, critical illness, health and dental protection, and creditor insurance products; and retirement and wealth savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations.
Further Reading
Before you consider Great-West Lifeco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Great-West Lifeco wasn't on the list.
While Great-West Lifeco currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.